Pharma R&D Review: What Changed In 2018, What To Look Out For In 2019

The drug R&D pipeline in 2019, and how it is changing
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Let’s talk TOC and conductivity requirements for pharmaceutical water systems

europeanpharmaceuticalreview

This webinar addresses the requirements for continuous monitoring of water for injection (WFI) systems and how this can be achieved with total organic carbon (TOC) and conductivity. It will also cover cold WFI production according to EP and how it applies to water systems.
Watch Now

New Drug Pricing Strategies for a Changing Global Market

questexweb

Biopharmaceutical companies are increasingly challenged to create a drug pricing strategy that both rewards value and innovation, and promotes affordability and access. During this webinar, PwC’s Health Research Institute will review findings from a new global survey of industry executives, and provide analysis and commentary on key drug pricing issues, including:
Watch Now

WEBINAR Improve efficiency and return on investment by adopting molecular spectroscopy techniques in pharma manufacturing

In this on-demand webinar, discover the differences between FTIR, NIR and Raman spectroscopy, learn how spectroscopy is applied in quality control labs and hear how implementation of these techniques increased efficiency and minimised costs.
Watch Now

A Clinical Perspective on Sexually Transmitted Infections: What is the State of Play

LabRoots Inc.

Sexually transmitted infections (STIs) continue to affect most sexually active populations across the globe, especially the traditional high-risk groups for bacterial STIs such as young people, men who have sex with men (MSM) and individuals from black and minority ethnic populations. Bacterial STIs such as Gonorrhoea and Chlamydia remain common. In western settings, we have observed the re-emergence of high rates of syphilis and lymphogranuloma venereum, mostly in MSM. Urethral and vaginal discharge syndromes, genital ulcer disease are frequent clinical presentations. However, the development of highly sensitive molecular assays has revealed that asymptomatic infections are also common, particularly at extragenital sites, and probably drive transmission of STIs.
Watch Now